Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient-is the time right to revise probiotic safety guidelines?

Clinical Microbiology and Infection

Volumn 17, Issue 10, 2011, Pages 1589-1592

  Kochan, P ^a,b   Chmielarczyk, A ^a   Szymaniak, L ^c   Brykczynski, M ^c   Galant, K ^c   Zych, A ^c   Pakosz, K ^a   Giedrys Kalemba, S ^c   Lenouvel, E ^a   Heczko, P B ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Polish Society for Probiotics and Prebiotics   (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Adverse events; Aortic valve replacement; Endocarditis; Lactobacillus; Perioperative care; Probiotics; Safety; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; AORTA VALVE REPLACEMENT; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BLOOD CULTURE; CASE REPORT; DRUG SAFETY; DRUG USE; FEMALE; FEVER; GASTROINTESTINAL DISEASE; GRAM POSITIVE INFECTION; HUMAN; LACTOBACILLUS RHAMNOSUS; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SEPSIS; SURGICAL PATIENT;

LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS;

EID: 80053052087     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03614.x     Document Type: Article

References (9)

1. Liong M. Safety of probiotics: translocation and infection. Nutr Rev 2008; 66: 192-202.
2. Cannon J, Lee T, Danziger L. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 2005; 24: 31-40.
3. Whelan K, Myers CE. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr 2010; 91: 687-703.
4. Sanders M, Akkermans L, Haller D et al. Safety assessment of probiotics for human use. Gut Microbes 2010; 1: 1-22.
5. Salminen M, Rautelin H, Tynkkynen S et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 2004; 38: 62-69.
6. Besselink MG, van Santvoort HC, Buskens E et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371: 651-659.
7. Tynkkynen S, Satokari R, Saarela M, Mattila-Sandholm T, Saxelin M. Comparison of ribotyping, randomly amplified polymorphic DNA analysis, and pulsed-field gel electrophoresis in typing of Lactobacillus rhamnosus and L. casei strains. Appl Environ Microbiol 1999; 65: 3908-3914.
8. Luong M, Sareyyuoglu B, Nguyen M et al. Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection? Transpl Infect Dis 2010; 12: 561-564.
9. Lawrence D, Dulchavsky S, Brown W. Splanchnic ischemia and bacterial translocation in the abdominal compartment syndrome. J Trauma 1997; 43: 852-855.